您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Theliatinib
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Theliatinib
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Theliatinib图片
CAS NO:1353644-70-8
包装与价格:
包装价格(元)
1 mg电议
5 mg电议
10 mg电议
25 mg电议
50 mg电议
100 mg电议
1 mL*10 mM(in DMSO)电议

产品名称
席栗替尼
西利替尼
产品介绍
Theliatinib 是一种ATP 竞争性、口服活性和高度选择性的EGFR抑制剂,Ki为 0.05 nM,IC50为 3 nM。它具有抗肿瘤活性,对EGFR T790M/L858R突变体的IC50值为 22 nM。它对EGFR的选择性是其他激酶的 50 倍以上。

产品描述

Theliatinib, a potent and highly selective EGFR inhibitor, with anti-tumor activity. Ki of 0.05 nM for wild type EGFR, and IC50s of 3 and 22 nM for EGFR and EGFR T790M/L858R mutant, respectively.

体外活性

In vitro studies suggest that Theliatinib is a potent EGFR kinase inhibitor with good kinase selectivity.

体内活性

In vivo data demonstrated broad spectrum anti-tumor activity via oral dosing in multiple xerographs such as A-431, Bcap-37 and Fadu. Two PDECX models with EGFR gene amplification (PDECX1T0326 and PDECX1T0950) were sensitive to theliatinib treatment demonstrating tumor regression of 32% and 75%, respectively.

动物实验

Seven- to nine week old NOD-SCID immunodeficient or BALB/cASlac-nu/nu male or female mice. Fresh tumor specimens from newly diagnosed patients were collected during surgery and separated into three parts for the following: (1) To prepare formalin fixed paraffin embedded (FFPE) sections; (2) For snap freezing in liquid nitrogen for DNA extraction and sequencing and (3) For subcutaneous implantation into NOD-SCID mice (P0) and subsequent passages in additional NOD-SCID or nude mice once the tumor size reached 800~1500 mm^3. After several consecutive in vivo passages, the PDECX models (P3~P7) were used to evaluate the anti-tumor efficacy of theliatinib or gefitinib or AZD4547.

Cas No.

1353644-70-8

分子式

C25H26N6O2

分子量

442.523

别名

席栗替尼;西利替尼;Theliatinib

储存和溶解度

DMSO:47 mg/mL (106.21 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years